InvestorsHub Logo
Followers 66
Posts 12723
Boards Moderated 0
Alias Born 06/03/2015

Re: attilathehunt post# 435895

Thursday, 10/19/2023 11:58:26 AM

Thursday, October 19, 2023 11:58:26 AM

Post# of 462216
As Missling stated, it has to do with drug pricing... which should be viewed as a favorable strategy for shareholders.
I presume that AD NDA filing for TGA (and UK, EU) will be soon after FDA.
There is no "compassionate use" in AU... other than an SAS for ongoing treatment for trial patients.
It's possible that doctors could use SAS to gain access for their AD patients, but an application must be made.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News